covid19
Showing NaN - NaN of 33
Covid19 Trial in Rio De Janeiro, São Paulo (ISIS 721744, Normal Saline)
Completed
- Covid19
- ISIS 721744
- Normal Saline
-
Rio De Janeiro, Brazil
- +2 more
Sep 21, 2022
Covid19, SARS-CoV Infection Trial in Brazil (Hospital admission, Non-hospitalization procedures)
Active, not recruiting
- Covid19
- SARS-CoV Infection
- Hospital admission
- Non-hospitalization procedures
-
Arapiraca, Alagoas, Brazil
- +13 more
Aug 3, 2022
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
Covid19, SARS (Severe Acute Respiratory Syndrome), SARS-CoV Infection Trial in Sao Paulo (Exercise training)
Recruiting
- Covid19
- +2 more
- Exercise training
-
Sao Paulo, BrazilUniversity of Sao Paulo
Jun 10, 2022
Exploratory Study: COVID-19 and Pregnancy
Recruiting
- Pregnant Women
- Covid19
- SARS-CoV-2 serology
-
São Paulo, BrazilRossana P Fracisco
Jun 7, 2022
Covid19 Trial in Worldwide (Novaferon, Placebo)
Recruiting
- Covid19
- Novaferon
- Placebo
-
Bahia Blanca, Argentina
- +87 more
Jun 1, 2022
Covid19 Trial in Sao Paulo (PRAYER)
Completed
- Covid19
- PRAYER
-
Sao Paulo, SP, BrazilHospital do Coracao
Mar 16, 2022
Covid19 Trial in Brazil (COVI-MSC, Placebo)
Recruiting
- Covid19
- COVI-MSC
- Placebo
-
Salvador, BA, Brazil
- +5 more
Mar 14, 2022
Covid19 Trial in Sao Paulo (CPC+ZN, CPC, Negative Control)
Completed
- Covid19
- CPC+ZN
- +2 more
-
Sao Paulo, BrazilHospital israelita Albert Einstein
Feb 24, 2022
Covid19, Pulmonary Embolism Trial in São Paulo, Milano (Optical Coherence Tomography (OCT))
Completed
- Covid19
- Pulmonary Embolism
- Optical Coherence Tomography (OCT)
-
São Paulo, Brazil
- +1 more
Oct 26, 2021
Covid19, Angiotensin II Receptor Antagonist Adverse Reaction Trial in São Paulo (Renin-angiotensin system inhibitors)
Terminated
- Covid19
- Angiotensin II Receptor Antagonist Adverse Reaction
- Renin-angiotensin system inhibitors
-
São Paulo, SP, BrazilInstituto do Coração - Incor HCFMUSP
Sep 28, 2021
Covid19 Trial in Brazil (Tofacitinib 10 mg, Placebo)
Completed
- Covid19
- Tofacitinib 10 mg
- Placebo
-
Aracaju, Brazil
- +16 more
Aug 2, 2021
Covid19 Trial in Worldwide (Trimodulin, Placebo (human albumin 1%))
Active, not recruiting
- Covid19
- Trimodulin
- Placebo (human albumin 1%)
-
Porto Alegre, Brazil
- +16 more
Jun 15, 2021
PTSD, Covid19 Trial in Salvador, Recife, São Paulo (Trial-Based Cognitive Therapy, Mindfulness-Based Health Promotion, Positive
Recruiting
- Posttraumatic Stress Disorder
- Covid19
- Trial-Based Cognitive Therapy
- +2 more
-
Salvador, Bahia, Brazil
- +3 more
Apr 20, 2021
Adsorbed COVID-19 (Inactivated) Vaccine
Not yet recruiting
- Covid19
- Adsorbed COVID-19 (Inactivated) Vaccine
-
Botucatu, São Paulo, Brazil
- +2 more
Apr 12, 2021
Covid19, Hospitalization Trial in Brazil (Data collection)
Enrolling by invitation
- Covid19
- Hospitalization
- Data collection
-
Salvador, Bahia, Brazil
- +12 more
Mar 18, 2021
Covid19, Thrombosis Trial in Barbalha, São Paulo, Bragança Paulista (Apixaban 2.5 MG, Placebo)
Recruiting
- Covid19
- Thrombosis
- Apixaban 2.5 MG
- Placebo
-
Barbalha, Ceará, Brazil
- +3 more
Mar 15, 2021
COvid-19 REgistry on THROMBOSIS Complications
Recruiting
- Covid19
-
Campinas, Brazil
- +30 more
Mar 2, 2021
Acute Respiratory Distress Syndrome, Covid19, Myocardial Injury Trial in Sao Paulo (Trimetazidine)
Unknown status
- Acute Respiratory Distress Syndrome
- +2 more
-
Sao Paulo, SP, BrazilHeart Institute (InCor-HCFMUSP)
Feb 18, 2021